Last reviewed · How we verify
Omegacin (BIAPENEM)
Omegacin (generic name: BIAPENEM) is a biapenem drug. It is currently FDA-approved.
Omegacin is a small molecule antibiotic. It is also known by the synonyms BIAPENEM.
At a glance
| Generic name | BIAPENEM |
|---|---|
| Drug class | biapenem |
| Target | D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5, D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6, Penicillin-binding protein 1 |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Population Pharmacokinetics and Dosage Individualization of Antibiotics in Elderly Patients
- Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections
- Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination (PHASE1)
- Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Omegacin CI brief — competitive landscape report
- Omegacin updates RSS · CI watch RSS
Frequently asked questions about Omegacin
What is Omegacin?
Omegacin (BIAPENEM) is a biapenem drug.
What is the generic name of Omegacin?
BIAPENEM is the generic (nonproprietary) name of Omegacin.
What drug class is Omegacin in?
Omegacin belongs to the biapenem class. See all biapenem drugs at /class/biapenem.
What development phase is Omegacin in?
Omegacin is FDA-approved (marketed).
What does Omegacin target?
Omegacin targets D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5, D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6, Penicillin-binding protein 1 and is a biapenem.
Related
- Drug class: All biapenem drugs
- Target: All drugs targeting D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5, D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6, Penicillin-binding protein 1
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing